CRISPR DNA Helix fragments

Streamlining CRISPR gene editing

CRISPR-mediated gene editing is a versatile technology with an unprecedented potential to transform many areas of life science. It’s no surprise that CRISPR technology won the Noble Prize in Chemistry in 2020 and continues to find new applications – from treating genetic diseases to ensuring food security.  

Compared with other technologies, genome editing using the CRISPR-Cas9 system is affordable and straightforward, but there are still challenges to overcome. For example, inefficiencies in editing can make it cumbersome to characterize gene edits.  

At QIAGEN, our technologies and dedicated workflows make it quicker and easier to create (clone), characterize and analyze gene editing events.

Check out the workflow-specific tabs above to learn more.

CRISPR Cas9 editing
Male biochemist running samples in the laboratory

Due to its immense potential to modify the genomes of consenting humans and future generations, we at QIAGEN truly appreciate the complex ethical considerations of using CRISPR technology. We endorse in full the principles and proposals of scientific organizations and advisory groups – such as the American Society of Human Genetics (ASHG) and the European Society of Human Genetics (ESHG) – that have issued cautionary guidelines.